These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 25161098
1. SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells. Zhang W, Zeng Z, Wei F, Chen P, Schmitt DC, Fan S, Guo X, Liang F, Shi L, Liu Z, Zhang Z, Xiang B, Zhou M, Huang D, Tang K, Li X, Xiong W, Tan M, Li G, Li X. FEBS J; 2014 Nov; 281(21):4815-29. PubMed ID: 25161098 [Abstract] [Full Text] [Related]
2. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling. Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W. FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612 [Abstract] [Full Text] [Related]
3. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway. Ou C, Sun Z, Zhang H, Xiong W, Ma J, Zhou M, Lu J, Zeng Z, Bo X, Chen P, Li G, Li X, Li X. Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128 [Abstract] [Full Text] [Related]
4. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, Zhang WL, Zhao J. Mol Immunol; 2006 Apr; 43(11):1864-71. PubMed ID: 16364440 [Abstract] [Full Text] [Related]
5. Transcriptional up-regulation of restin by all-trans retinoic acid through STAT1 in cancer cell differentiation process. Fu H, Yang G, Lu F, Wang R, Yao L, Lu Z. Biochem Biophys Res Commun; 2006 May 19; 343(4):1009-16. PubMed ID: 16574066 [Abstract] [Full Text] [Related]
6. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. Li YH, Hu CF, Shao Q, Huang MY, Hou JH, Xie D, Zeng YX, Shao JY. J Transl Med; 2008 Jan 03; 6():1. PubMed ID: 18171482 [Abstract] [Full Text] [Related]
7. New insights on the palate, lung, and nasal epithelium clone (PLUNC) proteins: Based on molecular and functional analysis of its homolog of YH1/SPLUNC1. Liu H, Zhang X, Wu J, French SW, He Z. Exp Mol Pathol; 2016 Jun 03; 100(3):363-9. PubMed ID: 26654795 [Abstract] [Full Text] [Related]
8. [Analysis of splicing variants in NASG 3'UTR, down-regulated in nasopharyngeal carcinoma, and its expression in multiple cancer tissues]. Zhang BC, Zhu SG, Xiang JJ, Zhou M, Nie XM, Xiao BY, Li XL, Li GY. Ai Zheng; 2003 May 03; 22(5):477-80. PubMed ID: 12753706 [Abstract] [Full Text] [Related]
14. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival. Liao WT, Song LB, Zhang HZ, Zhang X, Zhang L, Liu WL, Feng Y, Guo BH, Mai HQ, Cao SM, Li MZ, Qin HD, Zeng YX, Zeng MS. Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):508-14. PubMed ID: 17255272 [Abstract] [Full Text] [Related]
15. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4. Hayashi K, Goodison S, Urquidi V, Tarin D, Lotan R, Tahara E. Int J Oncol; 2003 Mar 15; 22(3):623-9. PubMed ID: 12579317 [Abstract] [Full Text] [Related]
16. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Cheng AL, Huang WG, Chen ZC, Zhang PF, Li MY, Li F, Li JL, Li C, Yi H, Peng F, Duan CJ, Xiao ZQ. J Proteome Res; 2008 Jun 15; 7(6):2415-26. PubMed ID: 18433155 [Abstract] [Full Text] [Related]
17. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Ozpolat B, Akar U, Steiner M, Zorrilla-Calancha I, Tirado-Gomez M, Colburn N, Danilenko M, Kornblau S, Berestein GL. Mol Cancer Res; 2007 Jan 15; 5(1):95-108. PubMed ID: 17259349 [Abstract] [Full Text] [Related]
18. Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma. Zou G, Ren B, Liu Y, Fu Y, Chen P, Li X, Luo S, He J, Gao G, Zeng Z, Xiong W, Li G, Huang Y, Xu K, Zhang W. Cancer Sci; 2018 Nov 15; 109(11):3416-3427. PubMed ID: 30151927 [Abstract] [Full Text] [Related]